{"DataElement":{"publicId":"2006132","version":"2","preferredName":"Disease Histologic Diagnosis Ind","preferredDefinition":"the yes/no indicator that asks whether the patient's malignancy was histologically verified at diagnosis.","longName":"DZ_HIST_DX_IND","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2014077","version":"1","preferredName":"Disease Diagnosis","preferredDefinition":"the diagnosis for the patient's cancer.","longName":"DZ_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177151","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A disease is any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. (from Wikipedia)","longName":"Disease","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A50-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Updated to add EVS concept preferred name. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177541","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"Diagnosis","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C6-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3E7C21A-E29E-4BC2-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-10","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018981","version":"1","preferredName":"Disease Histologic Diagnosis Ind","preferredDefinition":"the yes/no indicator that asks whether the patient's malignancy was histologically verified at diagnosis.","longName":"DZ_HIST_DX_IND","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE653C6-BC56-1199-E034-0003BA12F5E7","beginDate":"2002-08-22","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE653C6-BC58-1199-E034-0003BA12F5E7","beginDate":"2002-08-22","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Patient has either a brain stem or optic pathway tumor","valueDescription":"Patient has either a brain stem or optic pathway tumor","ValueMeaning":{"publicId":"2563886","version":"1","preferredName":"Patient has either a brain stem or optic pathway tumor","longName":"2563886","preferredDefinition":"Patient has either a brain stem or optic pathway tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C69B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-31","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-31","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEE653C6-BC5A-1199-E034-0003BA12F5E7","beginDate":"2002-12-31","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2188676","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"Indicator","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E49C180D-8C09-0916-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEE64C67-C66D-1183-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"REEVESD","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]}],"AlternateNames":[{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"DZ_HIST_DX_IND","type":"USED_BY","context":"CTEP"},{"name":"DZ_HIST_DX_IND","type":"USED_BY","context":"COG"},{"name":"DZ_HIST_DX_IND","type":"USED_BY","context":"CITN"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"IE_IEORRES_DXHIS","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Does patient have histologic","type":"Preferred Question Text","description":"Does patient have histologic verification of the malignancy at original diagnosis?","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Does patient have histologic verification of the malignancy at the indicated time point","url":null,"context":"CTEP"},{"name":"CRF Text 3","type":"Alternate Question Text","description":"Patients must have malignant melanoma validated by histology or cytology.  Patient may have had primary cutaneous, mucosal, or ocular melanoma or metastasis from an unknown primary site.","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Was the relapse/progression proven by biopsy and histology?","url":null,"context":"CTEP"},{"name":"CRF Text 4","type":"Alternate Question Text","description":"Patients must have histologically confirmed melanoma that is metastatic or unresectable and for which standard curative or palliative measures do not exist or are no longer effective. The primary site may be cutaneous or unknown, but mucosal and ocular primaries are excluded","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 2","type":"Alternate Question Text","description":"Does the patient have newly diagnosed Ewing sarcoma or PNET confirmed by institutional pathologist?","url":null,"context":"COG"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"Does patient have a newly diagnosed and histopathologically confirmed, potentially resectable NRSTS of the extremity or trunk?","url":null,"context":"CTEP"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Was the relapse/progression/metastases proven by biopsy and histology?","url":null,"context":"CTEP"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"Patient must have histological or cytological confirmed malignancy in the following disease groups: melanoma that is metastatic or unresectable, non-small cell lung carcinoma, renal cell carcinoma or squamous cell head and neck carcinoma, and for which standard curative or palliative measures do not exist or are no longer effective. The primary site may be cutaneous or unknown, but mucosal and ocular primaries are excluded.","url":null,"context":"CTEP"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"Does the patient have histologic proof or unequivocal cytological proof (fine needle aspiration, biopsy or two positive sputa) of SCLC","url":null,"context":"NRG"},{"name":"EA5123","type":"Alternate Question Text","description":"Has the N2 disease been confirmed histologically?","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Does patient have histologic verification of AML at original diagnosis?","url":null,"context":"CTEP"},{"name":"CITN","type":"Alternate Question Text","description":"Patient must have histological or cytological confirmed malignancy in the following disease groups: melanoma that is metastatic or unresectable, non-small cell lung carcinoma, renal cell carcinoma, sarcoma, colon carcinoma, non-Hodgkin lymphoma, squamous cell head and neck carcinoma, or cutaneous squamous cell carcinoma, and for which standard curative or palliative measures do not exist or are no longer effective. The primary site may be cutaneous or unknown, but mucosal and ocular primaries are excluded.","url":null,"context":"CITN"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Was the patient diagnosed with Acute Lymphoblastic Leukemia per the indicated criteria","url":null,"context":"COG"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Histologically proven diagnosis of synovial sarcoma by central pathology review.","url":null,"context":"Alliance"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Patient has diagnosis by local pathologist of synovial sarcoma.","url":null,"context":"Alliance"},{"name":"CRF Text9","type":"Alternate Question Text","description":"cytology/histologic confirmation of malignancy","url":null,"context":"Alliance"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Documented histologic or cytologic diagnosis of RCC","url":null,"context":"Alliance"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"Does patient have histologic verification of the malignancy at the indicated time point?","url":null,"context":"COG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Does the patient have AML with an IDH2 mutation identified from a peripheral blood or bone marrow sample at the time of diagnosis and/or relapsed/refractory disease?","url":null,"context":"COG"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Does patient have newly diagnosed, existing or recurrent desmoid tumor that is deemed not amenable to surgery?","url":null,"context":"COG"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Does patient have existing or recurrent desmoid tumor that is deemed not amenable to surgery?","url":null,"context":"COG"},{"name":"CRF Test 11","type":"Alternate Question Text","description":"Does the patient have pathologically (histologically or cytologically) proven diagnosis of renal cell carcinoma","url":null,"context":"NRG"},{"name":"NRG CRF_Text 1","type":"Alternate Question Text","description":"Does the patient have pathologically (histologically or cytologically) proven diagnosis of HER2-positive salivary gland cancer?","url":null,"context":"NRG"},{"name":"CRF Text 12","type":"Alternate Question Text","description":"Does the patient have histologically proven diagnosis of endometrial cancer?","url":null,"context":"NRG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Patient has previously untreated, de novo AML defined by >20% myeloblasts in the peripheral blood or bone marrow.","url":null,"context":"CCTG"},{"name":"NRG CRF_Text 2","type":"Alternate Question Text","description":"Does the patient have pathologic confirmation of epithelioid or biphasic MPM","url":null,"context":"NRG"},{"name":"CCTG_02","type":"Alternate Question Text","description":"Patient has pathologically proven diagnosis of lateralized oropharyngeal cancer (OPC) not involving or crossing midline?","url":null,"context":"CCTG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Does patient have the required diagnosis to be eligible for this study?","url":null,"context":"COG"},{"name":"NRG CRF Text 3","type":"Alternate Question Text","description":"Does the patient have pathologically (histologically or cytologically) proven diagnosis of Stage II or III non-small cell lung cancer with known PD-L1 status prior to registration?","url":null,"context":"NRG"},{"name":"COG CRF Text 13","type":"Alternate Question Text","description":"Does patient have histologic diagnosis (by institutional pathologist) of newly diagnosed high grade osteosarcoma?","url":null,"context":"COG"},{"name":"NRG CRF_Text 3","type":"Alternate Question Text","description":"Does the patient have pathologically (histologically or cytologically) proven diagnosis of Stage II or III non-small cell lung cancer with known PD-L1 status prior to registration","url":null,"context":"NRG"},{"name":"CCTG_03","type":"Alternate Question Text","description":"Patient has metastatic, histologically confirmed grade 1 or 2 well-differentiated midgut neuroendocrine tumours, including NETs of unknown primary thought to be of midgut origin, with positive Gallium-68 DOTATATE scan or Copper-64 DOTATATE scan within the last 3 years.","url":null,"context":"CCTG"},{"name":"CCTG_04","type":"Alternate Question Text","description":"Patient has metastatic, histologically confirmed grade 1 or 2 well-differentiated midgut neuroendocrine tumours, including NETs of unknown primary thought to be of midgut origin, with positive Gallium-68 DOTATATE scan or Copper-64 DOTATATE scan?","url":null,"context":"CCTG"},{"name":"ECOG-ACRIN - 1","type":"Alternate Question Text","description":"Does the patient have histologically confirmed HER2-positive primary invasive breast carcinoma per ASCO/CAP guidelines that had been determined by local testing?","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Does patient have histologically confirmed neuroblastoma or osteosarcoma that is recurrent or refractory and for which standard curative measures do not exist or are no longer effective?","url":null,"context":"COG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Does patient have newly diagnosed AJCC Stage II-IV nasopharyngeal carcinoma (NPC)?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BEE4C2EB-EB7A-117D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-11-02","changeDescription":"corrected errors.","administrativeNotes":"2023.11.2 AQT added per ticket request CADSR0003032. ak 2023.8.4 AQT added per ticket request CADSR0002685. ak 01/20/23 added AQT for ticket request CADSR0001948 for CCTG cjl; 12/22/22 added AQT for ticket number CADSR0001818 cjl; 11/15/22 added AQT for ticket request CADSR0001669 cjl 2022.11.15 AQT added for ticket request. ak","unresolvedIssues":null,"deletedIndicator":"No"}}